Download Files:
261 CAD – 2,496 CADPrice range: 261 CAD through 2,496 CAD
Products Details
Product Description
– Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research.
Web ID
– T76673
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Daniel Vt Catenacci, et al. Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design. Future Oncol. 2019 Jun;15(18):2073-2082.
CAS Number
– 1952272-74-0
Molecular Weight
Compound Purity
– 100% (SEC-HPLC)
Pathway
– Angiogenesis|||Tyrosine Kinase/Adaptors
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock